Recently, loss of BRCA1 function was shown to be associated with the expansion of breast cancer stem and progenitor cells, conferring a dependency on the expression of the polycomb repressor 2 complex protein EZH2 [45, 46]. This evidence concerns the gene EZH2 and breast carcinoma.